Antipneumococcal activity of MEN 10700, a new penem, compared with other compounds, by MIC and time-kill kinetics

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 3, 1999, Pages 381-384

  Pankuch, Glenn A ^a   Hoellman, Dianne B ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[[6 (1 HYDROXYETHYL) 2 METHYL 7 OXO 4 THIA 1 AZABICYCLO[3.2.0]HEPT 2 EN 3 YL]METHYL]METHYLAMINO]ACETAMIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CIPROFLOXACIN; CLARITHROMYCIN; IMIPENEM; MEROPENEM; PENEM DERIVATIVE; PENICILLIN G; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; HUMANS; KINETICS; LACTAMS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 0032884729     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.3.381     Document Type: Article

References (10)

1. Jacobs, M. R. & Appelbaum, P. C. (1995). Antibiotic-resistant pneumococci. Reviews of Medical Microbiology 6, 77-93.
2. Altamura, M., Perrotta, E., Sbraci, P., Pestellini, V., Arcamone, F., Cascio, G. et al. (1995). 2-Substituted penems with amino acid-related side chains: synthesis and antibacterial activity of a new series of β-lactam antibiotics. Journal of Medical Chemistry 38, 4244-56.
3. Hamilton-Miller, J. M. T. & Shah, S. (1997). In-vitro microbiological assessment of a new penem, MEN 10700. Journal of Antimicrobial Chemotherapy 39, 575-84.
4. Pankuch, G. A., Lichtenberger, C., Jacobs, M. R. & Appelbaum, P. C. (1996). Antipneumococcal activities of RP 59500 (quinupristin/ dalfopristin), penicillin G, erythromycin and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrobial Agents and Chemotherapy 40, 1653-6.
5. Ganguly, A. K., Afonso, A., Girijavallabhan, V. M. & McCombie, S. (1985). Synthesis and preliminary in-vitro profile of Sch 34343 - a new penem antibacterial agent. Journal of Antimicrobial Chemotherapy 15, Suppl. C, 1-4.
6. Phillips, I., Wise, R. & Neu, H. C. (1982). An oral penem antibiotic: Sch 29482. Journal of Antimicrobial Chemotherapy 9, Suppl. C, 1-247.
7. Inoue, M. & Mitsuhashi, S. (1994). In vitro antibacterial activity and β-lactamase stability of SY5555, a new oral penem antibiotic. Antimicrobial Agents and Chemotherapy 38, 1974-9.
8. Tanaka, M., Hohmura, M., Nishi, T., Sato, K. & Hayakawa, I. (1997). Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640. Antimicrobial Agents and Chemotherapy 41, 1260-8.
9. Utsui, Y., Takenouchi, T., Masuda, N., Domon, H., Kakuta, M., Ishii, C. et al. (1996). CS-834, a new oral carbapenem: II. In vitro evaluation of R-95867, the active metabolite of CS-834. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1996. Abstract F106, p. 118. American Society for Microbiology, Washington, DC.
10. Wise, R., Andrews, J. M. & Danks, G. (1983). Comparison of in vitro activity of FCE 22101, a new penem, with those of other β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 24, 909-14.